期刊文献+

微小RNA-187对前列腺癌细胞增殖和迁移的影响 被引量:2

Identification of microRNA-187 expression potential role in prostate cancer cell's proliferation and migration
原文传递
导出
摘要 目的 观察微小RNA(miRNA,miR)-187在前列腺癌中的表达及其对前列腺癌细胞增殖迁移的影响.方法 实时荧光定量聚合酶链反应(FQ-PCR)检测miR-187在6例高分化、18例中分化、9例低分化的前列腺癌及癌旁组织中的表达.将miR-187抑制物和阴性对照分别转染至前列腺癌细胞株DU145中.细胞计数法(CCK-8)、平板克隆法检测miR-187对DU145细胞增殖能力的影响;细胞划痕实验检测miR-187对DU145细胞株迁移能力的影响.结果 实时荧光定量聚合酶链反应检测结果提示,高分化组中癌组织和癌旁组织miR-187表达水平差异无统计学意义(P>0.05);中分化组和低分化组癌组织miR-187表达水平高于癌旁组织,分别为3.018、3.912倍,差异有统计学意义(P<0.05).中分化组癌组织中miR-187表达是高分化组癌组织的3.047倍(P<0.05);低分化组癌组织中miR-187表达是中分化组癌组织的1.787倍(P<0.05).CCK-8检测结果显示下调miR-187表达后,DU145细胞增殖速度较未处理组及miR-187 NC组下降58.65%和54.45%,差异有统计学意义(P<0.05).平板克隆形成实验结果显示下调miR-187表达后,细胞克隆形成率目较未处理组及miR-187 NC组降低14.5%,18.0%,差异有统计学意义(P<0.05).细胞划痕实验显示,培养24 h后miR-187 inhibitor组细胞间距离为未处理组和miR-187NC组的1.73、1.95倍.结论 miR-187在中、低分化的前列腺癌组织中高表达,抑制前列腺癌细胞DU145中的miR-187表达能够抑制前列腺癌增殖和迁移. Objective To observe the microRNA (miRNA,miR)-187 expression in prostate cancer and its roles in prostate cancer cell proliferation and migration.Methods real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) was used to detect miR-187 expression in six cases of well differentiated,eighteen cases of moderately differentiated and nine cases of poorly differentiated prostate cancer tissues.The miR-187 inhibitor and negative control were transfected into DU145 cells.Cell counting kit-8 (CCK-8) and colony formation assay were applied to measure cell proliferation;Cell wound healing assay was used to detect cell migration and invasion.Results The results of FQ-PCR suggest that:The expression level of miR-187 had no difference in well differentiated prostate cancer tissues and precancerous tissues.In moderately and poorly differentiated prostate cancers,the expression levels of miR-187 were higher than the precancerous tissues and the folds are 3.018 and 3.912 (P < 0.05).The expression of miR-187 was 3.047 fold higher in moderately differentiated prostate cancer than high and 1.787 fold higher in poorly differentiated prostate cancer than moderately.CCK-8 results showed that when miR-187 was inhibited,DU145 proliferation rate was declined to 58.65%,54.45% compared with the untreated group and miR-187 NC group (P <0.05).Colony formation experiments showed that after miR-187 was inhibited,the number of colony-forming cells were lower than the control group and the difference was statistically significant (P < 0.05).Cell wound healing assay showed the distance in miR-187 inhibitor was 1.73 and 1.95 folds than miR-187 NC and untreated group after 24 hours incubation.Conclusion The expression levels of miR-187 were higher in moderately and poorly differentiated prostate cancer tissues compared to precancerous tissues;Inhibition of miR-187 expression in DU145 prostate cancer cells can inhibit prostate cancer growth and migration.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第6期1285-1287,共3页 Chinese Journal of Experimental Surgery
基金 无锡市人民医院一研一题基金项目(YT201315)
关键词 前列腺癌 微小RNA 增殖 迁移 Prostate cancer MicroRNA Proliferation Migration
  • 相关文献

参考文献7

二级参考文献19

  • 1温星桥,李小娟,周祥福,蔡育彬,高新.不同p21活化激酶-6活性对前列腺癌细胞增殖的影响[J].中华泌尿外科杂志,2006,27(8):552-555. 被引量:4
  • 2Yang F, Li X, Sharma M, et al. Androgen receptor specifically inter- acts with a novel p21-activated kinase, PAK6. J Biol Chem,2001, 276 : 15345-15353.
  • 3Wen XQ,Li XJ,Liao B, et ai. Knockdown of p21-activated kinase in- hibits prostate cancer growth and enhances chemosensitivity to do- cetaxel. Urology ,2009,73 : 1407-1411.
  • 4He L, Hannon GJ. MiRNAs:small RNAs with a big role in gene regu- lation. Nat Rev Genet,2004,5:522-531.
  • 5Ma L, Temya-Feldstein J, Weinberg R, et al. Tumour invasion and metastasis initiated by miRNA-10b in breast cancer. Nature,2007, 449:682-688.
  • 6Gao P ,Tchernyshyov I ,Chang TC ,et al. C-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism. Na- ture ,2009,458:762-765.
  • 7Chhabra R, Dubey R, Saini N. Cooperative and individualistic func- tions of the miRNAs in the aliR-23a - 27a - 24-2 cluster and its im- plication in human diseases. Molecular Cancer,2010,9:232.
  • 8Gottardo F,Liu CC erracin M,et al. Micro-RNA profiling in kidney and bladder cancens. U rol Oncol, 2007,25 : 387-392.
  • 9Saumet A, Vetter G, Bouttier M, et al. Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood,2009,113:412-421.
  • 10王国民,陈伟.前列腺癌与肿瘤干细胞研究的意义及前景[J].中华实验外科杂志,2007,24(10):1162-1163. 被引量:7

共引文献773

同被引文献25

  • 1陈宏,姜浩,张志伟.人核糖体蛋白L6对白血病K562/A02细胞耐药性的影响[J].实用癌症杂志,2006,21(2):117-119. 被引量:2
  • 2Liu L,Qu W,Zhong Z.Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC[J].Int J Clin Exp Pathol,2015;8(5):5609-13.
  • 3Guo J,Liu X,Wang M.miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer[J].Biochem Biophys Res Commun,2015;464(4):1302-8.
  • 4Peng Y,Liu YM,Li LC,et al.microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition[J].Oncol Lett,2014;7(4):1233-8.
  • 5Zhou J,Wang W.Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell[J].J Surg Oncol,2011;104(3):278-83.
  • 6Duregon E,Rapa I,Votta A,et al.MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations[J].Hum Pathol,2014;45(8):1555-62.
  • 7Zhou B,Ma R,Si W,et al.MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth[J].Cancer Lett,2013;333(2):159-69.
  • 8Chong Y,Zhang J,Guo X,et al.MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM[J].PLo S One,2014;9(12):e114585.
  • 9Zhang Y,Chen X,Lian H,et al.MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1 R[J].Oncol Rep,2014;31(3):1445-52.
  • 10Li N,Zhang F,Li S,et al.Pigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell[J].Biochem Biophys Res Commun,2014;444(4):611-6.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部